chr10:43572475:> Detail (hg19) (RET)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr10:43,572,475-43,625,799 |
| hg38 | chr10:43,077,027-43,130,351 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| lung adenocarcinoma | B |
Prognostic
|
Supports
|
Poor Outcome | Somatic | 3 | 24037524 | Detail | |
| breast cancer | Vandetanib | D |
Predictive
|
Supports
|
Sensitivity/Response | Somatic | 2 | 26686064 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| ASCL1 and RET mRNA levels were examined in lung cancer samples. High expression of RET (RET-high) co... | CIViC Evidence | Detail |
| Vandetanib was tested in 4 murine models of patient-derived xenografts. In xenografts with high expr... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr10:43,572,475-43,625,799
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- EXPRESSION
- Transcript 1 (CIViC Variant)
- ENST00000355710.3
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/295
Genome browser